Ketoconazole With or Without Alendronate Sodium in Treating Patients With Metastatic Prostate Cancer

Stopped early · Phase 2

Conditions studied: Stage IV Prostate Cancer, Bone Metastases, Adenocarcinoma of the Prostate, Recurrent Prostate Cancer

In brief

RATIONALE: Ketoconazole may suppress the production of hormones and may interfere in the growth of prostate cancer cells. Alendronate sodium may be effective in preventing bone metastases and bone pain associated with prostate cancer. It is not known if ketoconazole is more effective with or without alendronate sodium. PURPOSE: Randomized phase II trial to study the effectiveness of ketoconazole with or without alendronate sodium in treating patients who have metastatic prostate cancer.

Key facts

Study ID

NCT00019695

Run by

National Cancer Institute (NCI)

Starts

1999-03-01

Expected to finish

2005-03-01

Last updated by the study team

2024-03-04

Who can join

Age: 18 and older. Sex: male. Healthy volunteers: not accepted.

Where it is running

• Medicine Branch — Bethesda, Maryland, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.